Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
2.670
-0.170 (-5.99%)
At close: Nov 18, 2025, 4:00 PM EST
2.633
-0.037 (-1.38%)
After-hours: Nov 18, 2025, 4:38 PM EST
Dermata Therapeutics Market Cap
Dermata Therapeutics has a market cap or net worth of $1.82 million as of November 18, 2025. Its market cap has decreased by -5.12% in one year.
Market Cap
1.82M
Enterprise Value
-2.78M
1-Year Change
-5.12%
Ranking
Category
Stock Price
$2.67
Market Cap Chart
Since the IPO on August 13, 2021, Dermata Therapeutics's market cap has decreased from $57.49M to $1.82M, a decrease of -96.83%. That is a compound annual growth rate of -55.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 17, 2025 | 1.94M | -29.74% |
| Dec 31, 2024 | 2.76M | 27.62% |
| Dec 29, 2023 | 2.16M | -56.38% |
| Dec 30, 2022 | 4.95M | -65.85% |
| Dec 31, 2021 | 14.49M | -74.79% |
| Aug 13, 2021 | 57.49M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 914.81B |
| Johnson & Johnson | 480.85B |
| AbbVie | 413.57B |
| UnitedHealth Group | 290.34B |
| AstraZeneca | 277.65B |
| Novartis AG | 255.14B |
| Merck & Co. | 230.48B |
| Abbott Laboratories | 226.11B |